Revolutionizing mRNA technology, Moderna leads in vaccine innovation, expanding into cancer therapeutics and rare disease treatments.
Pioneering gene-editing therapies, CRISPR Therapeutics focuses on treating genetic disorders through precise DNA modification and breakthrough biotechnology.
A leader in antiviral and oncology drugs, Gilead continues to innovate in HIV, hepatitis, and cancer treatment research.
Renowned for monoclonal antibody development, Regeneron drives growth with groundbreaking therapies for eye diseases, cancer, and immune disorders.
Dominating cystic fibrosis treatments, Vertex expands its pipeline with innovative genetic and cell-based therapies targeting rare diseases.